TCM
IDXX icon

TD Capital Management’s Idexx Laboratories IDXX Stock Holding History

TD Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Hold
21
– – ﹤0.01% 441
2026
Q1 		$11.8K Buy
21
+5
+31% +$3.21K ﹤0.01% 451
2025
Q4 		$10.8K Hold
16
– – ﹤0.01% 436
2025
Q3 		$10.2K Hold
16
– – ﹤0.01% 418
2025
Q2 		$8.58K Buy
16
+14
+700% +$6.7K ﹤0.01% 438
2025
Q1 		$840 Hold
2
– – ﹤0.01% 570
2024
Q4 		$827 Buy
+2
New +$877 ﹤0.01% 545

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

TD Capital Management's IDXX Position: Q2 2026 in Review

TD Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 21 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

TD Capital Management first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.8K in Q1 2026. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • TD Capital Management held 21 shares of Idexx Laboratories worth $11.1K as of Q2 2026.
  • TD Capital Management left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of TD Capital Management's portfolio in Q2 2026, its #441 holding.
  • TD Capital Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • TD Capital Management's Idexx Laboratories position peaked at $11.8K in Q1 2026.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on TD Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.